| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005 | 6170 | 2005 |
| A randomized trial of bevacizumab for newly diagnosed glioblastoma MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ... New England Journal of Medicine 370 (8), 699-708, 2014 | 2946 | 2014 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 2159 | 1998 |
| Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial B Fisher, J Dignam, N Wolmark, DL Wickerham, ER Fisher, E Mamounas, ... The Lancet 353 (9169), 1993-2000, 1999 | 1334 | 1999 |
| Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. B Fisher, J Dignam, N Wolmark, E Mamounas, J Costantino, W Poller, ... Journal of clinical oncology 16 (2), 441-452, 1998 | 1142 | 1998 |
| Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial ML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ... The Lancet 393 (10166), 40-50, 2019 | 1114 | 2019 |
| Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors B Fisher, J Dignam, J Bryant, A DeCillis, DL Wickerham, N Wolmark, ... JNCI: Journal of the National Cancer Institute 88 (21), 1529-1542, 1996 | 1073 | 1996 |
| Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS IL Wapnir, JJ Dignam, B Fisher, EP Mamounas, SJ Anderson, TB Julian, ... Journal of the National Cancer Institute 103 (6), 478-488, 2011 | 860 | 2011 |
| Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 … B Fisher, J Dignam, J Bryant, N Wolmark Journal of the National Cancer Institute 93 (9), 684-690, 2001 | 850 | 2001 |
| Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less B Fisher, J Bryant, JJ Dignam, DL Wickerham, EP Mamounas, ER Fisher, ... Journal of clinical oncology 20 (20), 4141-4149, 2002 | 744 | 2002 |
| Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer B Fisher, J Dignam, B Emir, J Bryant, A DeCillis, N Wolmark, ... Journal of the National Cancer Institute 89 (22), 1673-1682, 1997 | 656 | 1997 |
| Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience B Fisher, S Land, E Mamounas, J Dignam, ER Fisher, N Wolmark Seminars in oncology 28 (4), 400-418, 2001 | 655 | 2001 |
| Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17: intraductal carcinoma ER Fisher, J Dignam, E Tan‐Chiu, J Costantino, B Fisher, S Paik, ... Cancer 86 (3), 429-438, 1999 | 649 | 1999 |
| Radiation with or without antiandrogen therapy in recurrent prostate cancer WU Shipley, W Seiferheld, HR Lukka, PP Major, NM Heney, DJ Grignon, ... New England Journal of Medicine 376 (5), 417-428, 2017 | 622 | 2017 |
| Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27 EP Mamounas, SJ Anderson, JJ Dignam, HD Bear, TB Julian, ... Journal of clinical oncology 30 (32), 3960, 2012 | 608 | 2012 |
| Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer WR Lee, JJ Dignam, MB Amin, DW Bruner, D Low, GP Swanson, ... Journal of Clinical Oncology 34 (20), 2325, 2016 | 590 | 2016 |
| Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline JJ Griggs, PB Mangu, H Anderson, EP Balaban, JJ Dignam, WM Hryniuk, ... Journal of clinical oncology 30 (13), 1553-1561, 2012 | 590 | 2012 |
| Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and … SJ Anderson, I Wapnir, JJ Dignam, B Fisher, EP Mamounas, JH Jeong, ... Journal of Clinical Oncology 27 (15), 2466, 2009 | 506 | 2009 |
| Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer D Huo, F Ikpatt, A Khramtsov, JM Dangou, R Nanda, J Dignam, B Zhang, ... Journal of clinical oncology 27 (27), 4515, 2009 | 476 | 2009 |
| Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials B Fisher, JH Jeong, J Bryant, S Anderson, J Dignam, ER Fisher, ... The Lancet 364 (9437), 858-868, 2004 | 411 | 2004 |
